CDK5-IN-3
Based on 1 Customer Validation
CDK5-IN-3 is a CDK5 inhibitor. CDK5-IN-3 exhibits an IC50 of 0.6 μM against CDK5/p25, with a 30-fold selectivity over CDK2/CycA. CDK5-IN-3 can be used for research on CDK5-related diseases, such as autosomal dominant polycystic kidney disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.99%
- CAS No.: 2639542-32-6
- Formule: C22H26N4O
- Masse moléculaire:362.47
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
Description
IC50 & Target
[1]|
Cdk5/p25 0.6 nM (IC50) |
CDK2/CycA 18 nM (IC50) |
In Vitro
CDK5-IN-3 (compound 11) inhibits CDK5/p25 with an IC50 of 0.6 nM; its IC50 against CDK2/CycA is 18 μM, demonstrating 30-fold selectivity for CDK5/p25 over CDK2/CycA2[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2639542-32-6
-
Appearance Solid
-
Masse moléculaire 362.47
-
Formule C22H26N4O
-
Color Light yellow to yellow
-
SMILES
C[C@@](C1=CC=C2C(C=C(NC3=CC=CC=C3)N=C2)=N1)(O)C4CCN(C)CC4
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 10 mg/mL (27.59 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
-
Fiche technique (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7588 mL | 13.7942 mL | 27.5885 mL | 68.9712 mL |
| 5 mM | 0.5518 mL | 2.7588 mL | 5.5177 mL | 13.7942 mL | |
| 10 mM | 0.2759 mL | 1.3794 mL | 2.7588 mL | 6.8971 mL | |
| 15 mM | 0.1839 mL | 0.9196 mL | 1.8392 mL | 4.5981 mL | |
| 20 mM | 0.1379 mL | 0.6897 mL | 1.3794 mL | 3.4486 mL | |
| 25 mM | 0.1104 mL | 0.5518 mL | 1.1035 mL | 2.7588 mL |